Raymond James reiterates Universal Health Services stock rating
Raymond James maintained a Market Perform rating on Universal Health Services (UHS), citing Q3 results slightly below expectations and a cautious 2027 outlook. UHS stock is down 21% YTD, trading at $172.18. Analysts have lowered earnings estimates due to slower growth at new facilities. Despite near-term challenges, UHS is trading at a P/E ratio of 6.89, suggesting potential undervaluation.
How this was made
The 30-second read
Why it matters
The mixed earnings and lowered outlook drive short‑term downside, but the beat and low valuation could attract value investors.
Market read
UHS earnings and guidance revision are the primary market-moving elements; sector peers may be impacted by policy overhangs.
What to watch
Potential upside from upcoming facility ramps and possible policy relief for Medicaid.
Background
Raymond James provided an analyst note reiterating a Market Perform rating amid mixed Q3 results for Universal Health Services.
Ticker impact
Raymond James reiterated a Market Perform rating on UHS after Q3 earnings beat expectations but lowered outlook, causing the stock to fall 8.5% this week.
likely pressure as investors price in weaker guidance and policy overhangs
The earnings beat is offset by a cautious outlook for 2027 and a rating reiteration, which historically triggers short-term sell pressure.
Market effects
The healthcare services sector may see broader scrutiny of Medicaid policy risks.
U.S. hospital operators could face similar valuation pressure.
Limited to U.S. healthcare equities.
Counterpoint
The earnings beat and low P/E suggest undervaluation; the stock may rebound if guidance improves.
Key entities
- companyUniversal Health Services
U.S. healthcare services provider (ticker UHS).
- analyst_firmRaymond James
Equity research firm issuing the rating.




